HOME
PRINT
SEND

Directors and Officers



Stanley B. Stein
President & CEO



Stanley B Stein. President & CEO was a registered securities principal at Scarsdale Equities in New York, NY, focusing in healthcare and biotechnology. His investment banking experience covers 25 years and many complex transactions. Previously, he was Head of the North American Corporate Finance for Dresdner Bank. Stan also was a Managing Director at Drexel Burnham Lambert. He founded a small banking boutique, SRS Capital LLC, specializing in healthcare. He was a principal in creating Fresenius Medical Care, the largest renal care business in the world. Stan brings to Oragenics a network of biopharma companies, investment groups, and other business relationships. Stan received his B.A and J.D. from Columbia University in New York.




Jeffrey Hillman, DMD, PhD
Chief Scientific Officer



Dr. Jeffrey Hillman founded Oragenics to commercialize the fruits of 25 years of research at The Forsyth Dental Center in Boston and the University of Florida. He is currently a full professor at the University of Florida College of Dentistry; he has taken a leave of absence from his professorship to work on final development of these technologies.

Dr. Hillman has authored or co-authored more than 100 publications and textbook chapters on subjects related to the etiology and cure of caries (cavities) and periodontal (gum) disease. Dr. Hillman has demonstrated his management skills by administering tens of millions of dollars in grant funding and supervising graduate students and post-doctoral fellows on a routine basis.

Dr. Hillman received his undergraduate training at the University of Chicago (Phi Beta Kappa), his DMD degree (cum laude) from Harvard School of Dental Medicine and his PhD from Harvard Medical School.





Richard T. Welch
Chairman

Rick, Chairman of the Board is President of Welch Business Solutions and Consulting, LLC in Tampa, Florida, and has served as a Director and CFO for several healthcare companies, including Orthopedic Development Corporation, Albiorex, LLC, Medi-Spa's of America, Inc, and Vision Twenty-One. Previously, he served as executive vice-president of finance and administration, and earlier as CFO, for Sports and Recreation, Inc. Rick is also a CPA and received his BSc in management and accounting from Louisiana State University.




Derek Hennecke
Director

Derek, an independent Board member is an expert in drug development. He is a founder and CEO of Xcelience, a formulation and clinical manufacturing contract research company in Tampa, Florida. His management experiences over 25 years in the international biotechnology industry include; MDS Pharma Sciences, as Vice-president and General Manager for biopharmaceuticals, formulations, manufacturing, and pharmaceutics; DSM (contract manufacturing company) in active pharmaceutical ingredients, new business development (NBD) and manufacturing; and Biochemical Research Division of Boehringer Mannheim in NBD. His work included Europe, Egypt, Mexico, Canada, and USA. He earned a BSc, University of Alberta (Canada), and MBA, Erasmus University (Rotterdam, Netherlands).




Kevin H. Sills
Director

Mr. Sills an independent director is Vice President of Pharmaceutical Development of King Pharmaceuticals Research & Development. With more than 25 years related experience, he has primary responsibility for the company's varied pharmaceutical R&D activities, including novel formulation of new chemical entities; clinical supplies design/production and product life cycle management. With a BS in biology and medical technology from the University of North Carolina, Mr. Sills was also a past faculty member of the Center for Professional Advancement, President of NC Pharmaceutical Discussion Group, and an active member of the Licensing Executives Society and the American Assoc of Pharmaceutical Scientists.




Marc Siegel, MD.
Director

Marc is Clinical Associate Professor of Medicine at NYU School of Medicine and Medical Director of Doctor Radio with NYU and Sirius Satellite Radio. Dr. Siegel is a Fox News Medical Contributor, a columnist for the Los Angeles Times, a member of the Board of Contributors at USA Today, a regular contributor to the NY Post, and a frequent contributor to the Washington Post, the Wall Street Journal, and Newsday. He is also the author of two non-fiction books, including False Alarm: the Truth about the Epidemic of Fear, a Discover Magazine top-twenty book of 2005.



About Oragenics | Product Portfolio | Press Room | Investor Relations | Contact Us | Copyright Oragenics | Design by